Chad M. Robins
CEO and Chairman at Adaptive Biotechnologies. Based in Seattle, Washington.
- Rank
- 2282nd of 14,644
- Companies held
- 1
- Largest holding
- ADPT, 100.0% of total
- Latest SEC filing
- Nov 9, 2026
What the $58.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Adaptive Biotechnologies ADPT Common Stock | Directly | 2,080,518 | $28.05 | $58.4M | 100.0% | Form 4, Nov 9, 2026 |
Share counts are the amounts Chad M. Robins reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Sold | ADPT | 204 | $25.14 | $5K | View |
| Aug 18, 2026 | Sold | ADPT | 278,472 | $24.48 | $6.8M | View |
| Aug 17, 2026 | Sold | ADPT | 2,525 | $25.57 | $65K | View |
| Aug 17, 2026 | Sold | ADPT | 318,799 | $25.08 | $8.0M | View |
| Apr 8, 2026 | Sold | ADPT | 37,263 | $15.19 | $566K | View |
| Apr 6, 2026 | Sold | ADPT | 83,332 | $14.41 | $1.2M | View |
| Mar 11, 2026 | Sold | ADPT | 329,600 | $13.17 | $4.3M | View |
| Mar 11, 2026 | Sold | ADPT | 140,567 | $13.17 | $1.9M | View |
| Mar 3, 2026 | Sold | ADPT | 50,703 | $15.49 | $785K | View |
| Mar 3, 2026 | Sold | ADPT | 2,380 | $16.15 | $38K | View |
| Mar 2, 2026 | Sold | ADPT | 289,024 | $15.82 | $4.6M | View |
| Feb 27, 2026 | Sold | ADPT | 182,891 | $15.99 | $2.9M | View |
| Feb 2, 2026 | Sold | ADPT | 124,998 | $18.44 | $2.3M | View |
| Jan 5, 2026 | Sold | ADPT | 124,998 | $15.59 | $1.9M | View |
| Dec 1, 2025 | Sold | ADPT | 124,998 | $18.94 | $2.4M | View |
| Nov 26, 2025 | Sold | ADPT | 35,736 | $19.68 | $703K | View |
| Nov 12, 2025 | Sold | ADPT | 1,867 | $15.00 | $28K | View |
| Nov 11, 2025 | Sold | ADPT | 1,237 | $14.57 | $18K | View |
| Nov 10, 2025 | Sold | ADPT | 86,161 | $14.73 | $1.3M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2279 | Rachel L. Brand Executive Vice President, Walmart. Bentonville, AR | $58.5M |
| 2280 | Jeffrey N. Simmons PRESIDENT, CEO AND DIRECTOR, Elanco Animal Health. Indianapolis, IN | $58.5M |
| 2281 | Michael Miebach President & CEO, Mastercard. Purchase, NY | $58.5M |
| 2282 | Chad M. Robins CEO and Chairman, Adaptive Biotechnologies. Seattle, WA | $58.4M |
| 2283 | Amar K. Goel CHAIRMAN, CHIEF INNOVATION OFF, PubMatic. Redwood City, CA | $58.3M |
| 2284 | Rainer H. Bosselmann Insider, Argan. Arlington, VA | $58.2M |
| 2285 | Michael J. Murray EVP and COO, D.R. Horton. Arlington, TX | $58.2M |
Other Adaptive Biotechnologies insiders
All ADPT insiders- Harlan S Robins$22.8MChief Scientific Officer. #4699 overall
- Tycho Peterson$14.9MChief Financial Officer. #6474 overall
- Susan Bobulsky$10.9MChief Commercial Officer, MRD. #8231 overall
- Julie Rubinstein$10.6MPresident and COO. #8406 overall
- Kyle Piskel$7.2MChief Financial Officer. #11183 overall
- Francis Lo$6.3MChief People Officer. #12386 overall
Questions
How much stock does Chad M. Robins own?
Chad M. Robins holds $58,358,530 in listed stock based on SEC filings and current prices, mostly Adaptive Biotechnologies (ADPT). That ranks 2282nd on the Stock Rich List.
Is this Chad M. Robins's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Chad M. Robins last buy or sell stock?
The most recent open-market trade on file is a sale of 204 ADPT shares on Aug 18, 2026 at $25.14.